About: Systematic review of the adverse effects of cutaneous leishmaniasis treatment in the New World.

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Systematic review of the adverse effects of cutaneous leishmaniasis treatment in the New World. Goto Sponge NotDistinct Permalink

An Entity of Type : wikibase:Item, within Data Space : wikidata.demo.openlinksw.com associated with source document(s)

scientific article published on 21 March 2011

Attributes	Values
rdf:type	Item
description	videnskabelig artikel (da) article científic (ca) articolo scientifico (it) artigo científico (pt) bilimsel makale (tr) vedecký článok (sk) vetenskaplig artikel (sv) vědecký článek (cs) wetenschappelijk artikel (nl) wissenschaftlicher Artikel (de) научни чланак (sr) article scientifique (fr) наукова стаття, опублікована в березні 2011 (uk) scientific article published on 21 March 2011 (en) مقالة علمية نشرت في 21 مارس 2011 (ar) artículu científicu espublizáu en marzu de 2011 (ast)
publication date	wds:Q37855193-F7E17503-4C59-4EAF-A872-76F8D2675857
publication date	2011-03-21 00:00:00Z (xsd:dateTime)
language of work or name	wds:Q37855193-B24F672F-43F4-4024-BEF6-388F1F9420C9
language of work or name	English
author name string	wds:Q37855193-3FF3B48C-1F09-4678-B8ED-AD7C43AFF46A wds:Q37855193-684D8E71-B783-4B7D-9E5E-602810DE20C4 wds:Q37855193-961850FD-1A43-4E88-9A4A-9832BF61FCDB wds:Q37855193-CCCAD6E0-22E1-4D1F-BB3E-642098D03035 wds:Q37855193-E9CD240F-241A-422C-93ED-EE9AB3A7868C wds:Q37855193-F3160994-7445-4D01-A9B3-239ED5D86AC5
author name string	Maria M Martins Armando O Schubach Raquel V Oliveira Carlos A Andrade Luiz F Oliveira Mauro C Marzochi
rdfs:label	Systematic review of the adverse effects of cutaneous leishmaniasis treatment in the New World. (en) Systematic review of the adverse effects of cutaneous leishmaniasis treatment in the New World. (nl)
skos:prefLabel	Systematic review of the adverse effects of cutaneous leishmaniasis treatment in the New World. (en) Systematic review of the adverse effects of cutaneous leishmaniasis treatment in the New World. (nl)
name	Systematic review of the adverse effects of cutaneous leishmaniasis treatment in the New World. (en) Systematic review of the adverse effects of cutaneous leishmaniasis treatment in the New World. (nl)
author	wds:Q37855193-90728D66-8628-499E-B34F-79BD97B53FD0
author	Sonia R Passos
title	wds:Q37855193-1D09A5EF-7DB4-4AB9-8360-4D18A8C107E6
title	Systematic review of the adverse effects of cutaneous leishmaniasis treatment in the New World (en)
page(s)	wds:Q37855193-59B28EEF-AA5B-4897-95DA-2F12C997A693
page(s)	87-96
instance of	wds:Q37855193-E6FC71EB-5306-477B-BC52-433A0C5B7E13 wds:Q37855193-db36d1ef-0091-4fde-a162-88119cb3bdec
instance of	review article scholarly article
main subject	wds:Q37855193-6EA1BACB-ABEF-47F9-84D4-3AA8067AFDDC wds:Q37855193-C62F511B-A386-4634-874E-C40EDE2A9D8A
main subject	cutaneous leishmaniasis systematic review
PubMed ID	wds:Q37855193-E59A3384-3418-4B8A-A789-B4E6A17C756A
PubMed ID	http://rdf.ncbi.nlm.nih.gov/pubchem/reference/21420925
PubMed ID	21420925
published in	wds:Q37855193-4EDE489D-2180-454D-BFFD-DFADE680E323
published in	Acta Tropica
issue	wds:Q37855193-57FA2322-B009-49E6-86C0-5F1A5C45997D
volume	wds:Q37855193-6EED02D6-A4D4-4121-B7E7-4A0B9393DAE7
issue	2
volume	118
number of pages	wds:Q37855193-30762C32-2371-4C28-9715-2E9FF9268469
number of pages	10 (xsd:decimal)
DOI	wds:Q37855193-03F1E5A1-45A0-4A6A-ADDD-2F4720A5B926
DOI	http://dx.doi.org/10.1016/J.ACTATROPICA.2011.02.007
DOI	10.1016/J.ACTATROPICA.2011.02.007
ResearchGate publication ID	wds:Q37855193-259CF2F6-3DF6-402D-AE8A-D2AACF14CD62
ResearchGate publication ID	50594524
is about of	https://www.wikidata.org/wiki/Special:EntityData/Q37855193
is cites work of	Alteration of the serum biomarker profiles of visceral leishmaniasis during treatment Antigenicity and protective efficacy of a Leishmania amastigote-specific protein, member of the super-oxygenase family, against visceral leishmaniasis Antigenicity, Immunogenicity and Protective Efficacy of Three Proteins Expressed in the Promastigote and Amastigote Stages of Leishmania infantum against Visceral Leishmaniasis Therapeutic efficacy induced by the oral administration of Agaricus blazei Murill against Leishmania amazonensis The development and clinical evaluation of second-generation leishmaniasis vaccines. Leishmaniasis in the United States: treatment in 2012 Drug resistance in leishmaniasis: current drug-delivery systems and future perspectives. Monitoring toxicity associated with parenteral sodium stibogluconate in the day-case management of returned travellers with New World cutaneous leishmaniasis [corrected] Effects of miltefosine treatment in fibroblast cell cultures and in mice experimentally infected with Neospora caninum tachyzoites. Travelers with cutaneous leishmaniasis cured without systemic therapy In vitro activity of the hydroethanolic extract and biflavonoids isolated from Selaginella sellowii on Leishmania (Leishmania) amazonensis Efficacy of thermotherapy to treat cutaneous leishmaniasis: a meta-analysis of controlled clinical trials. Interventions for American cutaneous and mucocutaneous leishmaniasis: a systematic review update Meglumine Antimoniate (Glucantime) Causes Oxidative Stress-Derived DNA Damage in BALB/c Mice Infected by Leishmania (Leishmania) infantum Current status on prevention and treatment of canine leishmaniasis Prospective evaluation of serum pancreatic lipase immunoreactivity and troponin I concentrations in Leishmania infantum-infected dogs treated with meglumine antimonate In vitro antileishmanial, trypanocidal, and Mammalian cell activities of diverse n,n' -dihetaryl substituted diamines and related compounds Evaluation of antileishmanial activity of selected brazilian plants and identification of the active principles Strychnos pseudoquina and Its Purified Compounds Present an Effective In Vitro Antileishmanial Activity Identification of Th1/Th2 regulatory switch to promote healing response during leishmaniasis: a computational approach Local or systemic treatment for New World cutaneous leishmaniasis? Re-evaluating the evidence for the risk of mucosal leishmaniasis Chemotherapeutic potential of 17-AAG against cutaneous leishmaniasis caused by Leishmania (Viannia) braziliensis Human cellular and humoral immune responses to Phlebotomus papatasi salivary gland antigens in endemic areas differing in prevalence of Leishmania major infection Antileishmanial Activity of Ezetimibe: Inhibition of Sterol Biosynthesis, In Vitro Synergy with Azoles, and Efficacy in Experimental Cutaneous Leishmaniasis In vivo and in vitro effects of pentavalent antimony on mouse liver cytochrome P450s. Intranasal immunization with LACK-DNA promotes protective immunity in hamsters challenged with Leishmania chagasi. Diagnosis and Treatment of Leishmaniasis: Clinical Practice Guidelines by the Infectious Diseases Society of America (IDSA) and the American Society of Tropical Medicine and Hygiene (ASTMH). Low dose systemic or intralesional meglumine antimoniate treatment for American tegumentary leishmaniasis results in low lethality, low incidence of relapse, and low late mucosal involvement in a referral centre in Rio de Janeiro, Brazil (2001-2013) Burden of leishmaniasis in Brazil and federated units, 1990-2016: Findings from Global Burden of Disease Study 2016 Risk factors for therapeutic failure to meglumine antimoniate and miltefosine in adults and children with cutaneous leishmaniasis in Colombia: A cohort study.

Faceted Search & Find service v1.16.117 as of May 05 2024

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3239 as of May 5 2024, on Linux (x86_64-centos_6-linux-gnu), Single-Server Edition (378 GB total memory, 176 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software